-
Advancements in mRNA Vaccines: A Promising Approach for Combating Human Papillomavirus-Related Cancers Cancer Control (IF 2.6) Pub Date : 2024-03-11 Laraib Iqbal, Minal Jehan, Sumran Azam
The human papillomavirus (HPV) is a typical sexually transmitted disease that affects different epithelial cells and can cause a number of health problems. HPV is mainly spread through sexual contact and is extremely contagious, even in the absence of obvious symptoms. It is linked to a number of malignancies, such as oropharyngeal, cervical, anal, vulvar, vaginal, and cutaneous as well as anogenital
-
Stories to Prevent Cancer: A Pilot Study Using Cancer Survivor Narratives to Increase Human Papillomavirus Vaccine Intentions Cancer Control (IF 2.6) Pub Date : 2024-03-08 Chelsea M. Bufalini, Jennifer L. Kraschnewski, Timothy D. Riley, Kevin Wile, Katherine Spanos, Ashley Wong, Jessica Gall Myrick, Eric W. Schaefer, William A. Calo
IntroductionHuman papillomavirus (HPV) vaccination rates are lower than other recommended adolescent vaccines. Cancer survivor narratives are used to promote cancer prevention and control, but little is known about their impact on adolescent HPV vaccination.ObjectiveThis pilot study explored the feasibility and effects of a video education intervention using a cancer survivor narrative to improve parents’
-
A Pilot Study of Pembrolizumab Combined With Stereotactic Ablative Radiotherapy for Patients With Advanced or Metastatic Sarcoma Cancer Control (IF 2.6) Pub Date : 2024-03-07 Jeremy P. Harris, Jino Park, Eric Ku, Steven Seyedin, Russell Stitzlein, Amanda Goldin, Wen-Pin Chen, Christine McLaren, Allen M. Chen, Warren Chow
ObjectivesImmunotherapy with immune checkpoint inhibitors has shown only limited success in the management of metastatic soft tissue sarcoma. Overall response rates (ORR) with single agent pembrolizumab were 18% and median PFS was 18 weeks on the clinical trial SARC028. One strategy to improve the responses to immunotherapy is with stereotactic body radiation therapy (SBRT), which can enhance the antitumor
-
Radar-Guided Localization and Resection for Metastatic Nodal and Soft Tissue Melanoma: A Single-Institution Retrospective Study Cancer Control (IF 2.6) Pub Date : 2024-03-02 Kate E. Beekman, Danielle K. DePalo, Lily M. Parker, Kelly M. Elleson, John E. Mullinax, Amod A. Sarnaik, Vernon K. Sondak, Jonathan S. Zager
BackgroundRadar-guided localization (RGL) offers a wire-free, nonradioactive surgical guidance method consisting of a small percutaneously-placed radar reflector and handheld probe. This study investigates the feasibility, timing, and outcomes of RGL for melanoma metastasectomy.MethodsWe retrospectively identified patients at our cancer center who underwent RGL resection of metastatic melanoma between
-
Nomogram for Predicting Postoperative Pulmonary Metastasis in Hepatocellular Carcinoma Based on Inflammatory Markers Cancer Control (IF 2.6) Pub Date : 2024-03-01 Huanjie Zhou, Haiping Zheng, Ying Wang, Ming Lao, Hong Shu, Meifang Huang, Chao Ou
BackgroundUncertainty surrounds the usefulness of inflammatory markers in hepatocellular carcinoma (HCC) patients for predicting postoperative pulmonary metastasis (PM). The purpose of this study was to assess the predictive value of inflammatory markers as well as to create a new nomogram model for predicting PM.MethodsCox regression was utilized to identify independent prognostic variables and to
-
Epidemiology of Breast, Corpus Uteri, and Ovarian Cancers in Lebanon With Emphasis on Breast Cancer Incidence Trends and Risk Factors Compared to Regional and Global Rates Cancer Control (IF 2.6) Pub Date : 2024-02-29 Najla A. Lakkis, Reem M. Abdallah, Umayya M. Musharrafieh, Hanane G. Issa, Mona H. Osman
ObjectivesThis study explores the incidence and trends of breast (Bca), corpus uteri (CUca), and ovarian (Oca) cancer in Lebanon, a Middle Eastern country. It compares the Bca rates to regional and global ones and discusses Bca risk factors in Lebanon.IntroductionGlobally, Bca is the premier cause of cancer morbidity and mortality in women.MethodsData on female Bca, CUca, and Oca published by the Lebanese
-
Stapled Anastomosis Versus Hand-Sewn Anastomosis With Mucosectomy for Ileal Pouch-Anal Anastomosis: A Systematic Review and Meta-analysis of Postoperative Outcomes, Functional Outcomes, and Oncological Safety Cancer Control (IF 2.6) Pub Date : 2024-02-27 Mohamed Ali Chaouch, Mohammad Iqbal Hussain, Amine Gouader, Bassam Krimi, Alessandro Mazzotta, Adriano Carneira Da Costa, Niccolo Petrucciani, Mehdi Bouassida, Jim Khan, Faouzi Noomen, Hani Oweira
PurposeThis systematic review and meta-analysis aimed to compare outcomes between stapled ileal pouch-anal anastomosis (IPAA) and hand-sewn IPAA with mucosectomy in cases of ulcerative colitis and familial adenomatous polyposis.MethodsThis systematic review and meta-analysis was performed according to the Preferred Reporting Items for Systematic Review and Meta-analysis) guidelines 2020 and AMSTAR
-
MMP12 is a Potential Predictive and Prognostic Biomarker of Various Cancers Including Lung Adenocarcinoma Cancer Control (IF 2.6) Pub Date : 2024-02-27 Guo-Sheng Li, Yu-Xing Tang, Wei Zhang, Jian-Di Li, He-Qing Huang, Jun Liu, Zong-Wang Fu, Rong-Quan He, Jin-Liang Kong, Hua-Fu Zhou, Gang Chen
ObjectiveThis study sought to explore the clinical value of matrix metalloproteinases 12 ( MMP12) in multiple cancers, including lung adenocarcinoma (LUAD).MethodsUsing >10,000 samples, this retrospective study demonstrated the first pan-cancer analysis of MMP12. The expression of MMP12 between cancer groups and their control groups was analyzed using Wilcoxon rank-sum tests. The clinical significance
-
The Effects of Patient-Centered Communication on Patient Engagement, Health-Related Quality of Life, Service Quality Perception and Patient Satisfaction in Patients with Cancer: A Cross-Sectional Study in Türkiye Cancer Control (IF 2.6) Pub Date : 2024-02-27 Cuma Çakmak, Özgür Uğurluoğlu
IntroductionPatient-centered communication is a type of communication that takes place between the provider and the patient.ObjectivesIt is aimed to reveal the effects of patient-centered communication on patient engagement, health-related quality of life, perception of service quality and patient satisfaction.MethodThe study was conducted by applying multiple regression analysis to the data obtained
-
Geriatric Nutritional Risk Index Combined with Calf Circumference Can be a Good Predictor of Prognosis in Patients Undergoing Surgery for Gastric or Colorectal Cancer Cancer Control (IF 2.6) Pub Date : 2024-02-02 Xin Zheng, Jin-Yu Shi, Zi-Wen Wang, Guo-Tian Ruan, Yi-Zhong Ge, Shi-Qi Lin, Chen-An Liu, Yue Chen, Hai-Lun Xie, Meng-Meng Song, Tong Liu, Ming Yang, Xiao-Yue Liu, Li Deng, Ming-Hua Cong, Han-Ping Shi
ObjectivesTo explore the effect of combined hematological and physical measurement indicators on the prognosis of patients undergoing surgery for gastric or colorectal cancer and to screen for the best prognostic indicators.IntroductionGastric and colorectal cancer is a widespread health concern worldwide and one of the major contributors to cancer-related death. The hematological and physical measurement
-
Assessing Breast Cancer Screening and Outcomes Among First Nations Women in Alberta Cancer Control (IF 2.6) Pub Date : 2024-02-01 Angeline Letendre, Brittany Shewchuk, Bonnie A. Healy, Bonnie Chiang, Lea Bill, James Newsome, Chinmoy Roy Rahul, Huiming Yang, Karen A. Kopciuk
BackgroundBreast cancer (BC) incidence rates for First Nations (FN) women in Canada have been steadily increasing and are often diagnosed at a later stage. Despite efforts to expand the reach of BC screening programs for FN populations in Alberta (AB), gaps in screening and outcomes exist.MethodsExisting population-based administrative databases including the AB BC Screening Program, the AB Cancer
-
Adaptive Control of Tumor Growth Cancer Control (IF 2.6) Pub Date : 2024-01-31 Youcef Derbal
Cancer treatment optimizations select the most optimum combinations of drugs, sequencing schedules, and appropriate doses that would limit toxicity and yield an improved patient quality of life. However, these optimizations often lack an adequate consideration of cancer’s near-infinite potential for evolutionary adaptation to therapeutic interventions. Adapting cancer therapy based on monitored tumor
-
RAS Mutations Predict Recurrence-Free Survival and Recurrence Patterns in Colon Cancer: A Unicenter Study in Morocco Cancer Control (IF 2.6) Pub Date : 2024-01-25 Fatima El Agy, Sanae El Bardai, Sara Boukansa, Laila Bouguenouch, Zineb Benbrahim, Khalid Mazaz, El Bachir Benjelloun, Abdelmalek Ousadden, Karim Ouldim, Sidi Adil Ibrahimi, Laila Chbani
PurposeTo date, only a few studies have investigated the role of molecular alterations in cancer recurrence. This exploratory study aimed to evaluate the impact of molecular alterations on the time and site of recurrence in patients with stage I–IV CRC and to identify the risk factors predicting recurrence-free survival in colon cancer.MethodsA total of 270 patients were retrospectively included. We
-
Cyfra 21.1: A Useful Tumour Marker in Pancreatic Ductal Adenocarcinoma: Cross-Sectional Study Cancer Control (IF 2.6) Pub Date : 2024-01-22 Krishnakumar G. Kuttanchettiyar, Viswanathan Kollengode V, Meer M. Chisthi
BackgroundPancreatic cancer is a challenging disease, often requiring invasive procedures for diagnosis. Reliable tumour markers are essential for ensuring early detection and better patient outcomes. Although Carbohydrate Antigen 19-9 is the most commonly used marker, it is marred by low predictive accuracy and high false positivity. Carcino Embryonic Antigen also has limited practical use. A novel
-
Global, Regional, and National Incidence Trend Analysis of Malignant Skin Melanoma Between 1990 and 2019, and Projections Until 2034 Cancer Control (IF 2.6) Pub Date : 2024-01-16 Jin Yuan, Xiaoyang Li, Shengji Yu
BackgroundThe goal of this study was to evaluate the global burden of malignant skin melanoma (MSM) from 1990 to 2019 using MSM-related data from the Global Burden of Disease study.MethodsThe incidences’ relationships with the social-demographic index (SDI) and human developmental index (HDI) were investigated. To determine significant changes in incidence trends, the joinpoint regression model was
-
To Treat or Not to Treat? Dilemmas when Deciding on Antineoplastic Treatment in Patients With Far Advanced Cancers Cancer Control (IF 2.6) Pub Date : 2023-05-13 Carlos Eduardo Paiva, Daniel D’Almeida Preto, Crislaine de Lima, Bianca Sakamoto Ribeiro Paiva
Patients with advanced cancers and their oncologists are often faced with difficult treatment decisions, especially when there are borderline situations of expected benefit or increased risk of com...
-
A Winning New Combination? Toward Clinical Application in Oncology Cancer Control (IF 2.6) Pub Date : 2023-05-11 Quratulain Maqsood, Aleena Sumrin, Maryam Iqbal, Nazim Hussain, Muhammada Mahnoor, Muhammad Zafar Saleem, Rukhsana Perveen
Immunotherapy has substantial attention in oncology due to the success of CTLA-4 and PD-1 inhibitors in the treatment of melanoma, lung cancer, head and neck cancer, renal cell carcinoma, and Hodgk...
-
RNA-Sequencing Combined With Genome-Wide Allele-Specific Expression Patterning Identifies ZNF44 Variants as a Potential New Driver Gene for Pediatric Neuroblastoma Cancer Control (IF 2.6) Pub Date : 2023-05-10 Lan Sun, Xiaoqing Li, Lingli Tu, Andres Stucky, Chuan Huang, Xuelian Chen, Jin Cai, Shengwen Calvin Li
IntroductionNeuroblastoma (NB) is one of the children’s most common solid tumors, accounting for approximately 8% of pediatric malignancies and 15% of childhood cancer deaths. Somatic mutations in ...
-
Implementation of a Population-Based Cancer Family History Screening Program for Lynch Syndrome Cancer Control (IF 2.6) Pub Date : 2023-05-10 Sayoni Lahiri, Sara Pirzadeh-Miller, Kelsey Moriarty, Nisa Kubiliun
ObjectivesLynch syndrome increases risks for colorectal and other cancers. Though published Lynch syndrome cancer risk-management guidelines are effective for risk-reduction, the condition remains ...
-
Impact of Access to Breast Care For West Texas Program on Early Detection and Regional Breast Cancer Mortality Cancer Control (IF 2.6) Pub Date : 2023-05-09 Chathurika S Dhanasekara, Hafiz Khan, Rakhshanda L Rahman
IntroductionThis study aimed to assess whether the Access to Breast Care for West Texas (ABC4WT) program impacted regional breast cancer detection and mortality in the Texas Council of Governments ...
-
Comparison of Cancer Mortality and Incidence Between New Zealand and Australia and Reflection on Differences in Cancer Care: An Ecological Cross-Sectional Study of 2014-2018 Cancer Control (IF 2.6) Pub Date : 2023-05-07 Phyu Sin Aye, Shwe Sin Win, Sandar Tin Tin, J. Mark Elwood
BackgroundDespite many background similarities, New Zealand showed excess cancer deaths compared to Australia in previous studies. This study extends this comparison using the most recent data of 2...
-
Application of Comprehensive Genomic Profiling-Based Next-Generation Sequencing Assay to Improve Cancer Care in a Developing Country Cancer Control (IF 2.6) Pub Date : 2023-05-06 Claudia Cifuentes, Milton Lombana, Henry Vargas, Paola Laguado, Alejandro Ruiz-Patiño, Leonardo Rojas, Uriel Navarro, Carlos Vargas, Luisa Ricaurte, Oscar Arrieta, Lucia Zatarain-Barron, Leandro Zapata, Guido González, Carlos Ortiz, Laura Bernal, Juan G. Restrepo, Lucia Viola, Fabio Grosso, Ricardo Zapata, William Mantilla, Hernán Carranza, Iván Bustillo, Néstor Llinas, Ricardo Duarte, July Rodríguez
PurposeIdentifying actionable oncogenic mutations have changed the therapeutic landscape in different types of tumors. This study investigated the utility of comprehensive genomic profiling (CGP), ...
-
The Prevalence of Prostate Cancer Among Young Men Below 55 Years of Age in Nigeria Cancer Control (IF 2.6) Pub Date : 2023-05-02 Atara Ntekim, Ayorinde Folasire, Oluwaponmile A. Odukoya
IntroductionProstate cancer is the most common cancer in men. It was initially a disease of older men above the age of 55 years. Of recent, there has been reports of increase in the number of young...
-
Current Treatment of Potentially Resectable Pancreatic Ductal Adenocarcinoma: A Medical Oncologist’s Perspective Cancer Control (IF 2.6) Pub Date : 2023-04-28 Victor Hugo Fonseca de Jesus, Rachel P. Riechelmann
Pancreatic cancer has traditionally been associated with a dismal prognosis, even in early stages of the disease. In recent years, the introduction of newer generation chemotherapy regimens in the ...
-
The Efficacy and Safety of Tislelizumab as Adjuvant Treatment for Advanced or Metastatic Bladder Cancer in People Living With HIV: A Retrospective Multi-Center Study Cancer Control (IF 2.6) Pub Date : 2023-04-28 Menghua Wu, Xin Zheng, Xudong Wang, Xuyu Li, Yu Zhang, Jimao Zhao
BackgroundPeople living with HIV (PLWH) have a worse prognosis than the general population. Locally advanced or metastatic bladder cancer (BCa) in PLWH has gradually been increasing in recent years...
-
The Impact of Cancer Relapse and Poor Patient Outcomes on Health Care Providers Practicing in the Oncology Field Cancer Control (IF 2.6) Pub Date : 2023-04-25 Abdulrahman Alwhaibi, Miteb Alenazi, Bana Almadi, Nora aljabali, Sahar Alkhalifah, Wajid Syed, Reem Alsaif, Salmeen D Bablghaith, Mohammed N Al-Arifi
IntroductionDevastating cancer-related events are not uncommon, and these events have weakened communication performance and induced stress among health care providers (HCPs), particularly physicia...
-
Radiotherapy Increases aMMP-8-Levels and Neutrophil/Lymphocyte Ratio Rapidly in Head and Neck Cancer Patients: A Pilot Study Cancer Control (IF 2.6) Pub Date : 2023-04-24 Ella Brandt, Mutlu Keskin, Taina Tervahartiala, Mustafa Yılmaz, İlknur Harmankaya, Didem Karaçetin, Turgut İpek, Ulvi Kahraman Gürsoy, Jaana Rautava, Shipra Gupta, Jaana Hagström, Ismo T. Räisänen, Timo Sorsa
Radiotherapy for head and neck carcinoma (HNC) has both curative and palliative purposes. This study investigated mouthrinse aMMP-8 levels, molecular forms of MMP-8, blood neutrophil counts and neu...
-
Immune-Related Genes’ Prognostic, Therapeutic and Diagnostic Value in Ovarian Cancer Immune-Related Gene Biomarker in Ovarian Cancer Cancer Control (IF 2.6) Pub Date : 2023-04-20 Bo Ding, Wenjing Yan, Siyuan Shen, Dan Meng, Xue Chen, Shizhi Wang, Yang Shen
ObjectivesThe abnormal expression of immune-related genes (IRGs) plays an important role in the occurrence and progression of ovarian cancer (OC), which is the main cause of mortality among gynecol...
-
Brain Tumor Radiogenomic Classification of O6-Methylguanine-DNA Methyltransferase Promoter Methylation in Malignant Gliomas-Based Transfer Learning Cancer Control (IF 2.6) Pub Date : 2023-04-19 Houneida Sakly, Mourad Said, Jayne Seekins, Ramzi Guetari, Naoufel Kraiem, Mehrez Marzougui
Artificial Intelligence (AI) is the subject of a challenge and attention in the field of oncology and raises many promises for preventive diagnosis, but also fears, some of which are based on highl...
-
Prognostic Role of Pathological Complete Response in Early Stage Epithelial Solid Tumors Cancer Control (IF 2.6) Pub Date : 2023-04-19 Giuseppe Saltalamacchia, Antonio Bernardo, Erica Quaquarini
Neoadjuvant chemotherapy was originally designed to convert inoperable cancer. Nowadays, this concept has expanded since it can also offer the possibility to evaluate markers of response such as pa...
-
Pan-Cancer Study of the Prognosistic Value of Selenium Phosphate Synthase 1 Cancer Control (IF 2.6) Pub Date : 2023-04-18 Jie Hao, Ao-Yue He, Xu Zhao, Xue-Qin Chen, Qi-Ling Liu, Na Sun, Rong-Qiang Zhang, Ping-Ping Li
Objective: This study sought to determine the mean prognostic usefulness of seleniumphosphate synthase (SEPHS1) by investigating its expression in 33 human malignancies and its relationship to tumo...
-
Time of Clinic Appointment and Serious Illness Communication in Oncology Cancer Control (IF 2.6) Pub Date : 2023-04-18 Likhitha Kolla, Jinbo Chen, Ravi B. Parikh
IntroductionSerious illness communication in oncology increases goal concordant care. Factors associated with the frequency of serious illness conversations are not well understood. Given prior evi...
-
Weight Loss During Neoadjuvant Therapy Is Associated With Poor Response Among the Patients With Gastrointestinal Cancer: A Propensity Score Matching Analysis Cancer Control (IF 2.6) Pub Date : 2023-04-18 Zhaoting Bu, Yuting Jiang, Shanshan Luo, Xinxin He, Haiquan Qin, Weizhong Tang
PurposeThe aim of the current study was to identify the relationship between body composition changes during neoadjuvant therapy (NAT) and the treatment efficiency of NAT in gastrointestinal cancer...
-
Over-Expression of ARID3B Suppresses Tumor Progression and Predicts Better Prognosis in Patients With Gastric Cancer Cancer Control (IF 2.6) Pub Date : 2023-04-18 Xunlei Zhang, Xinyue Qiu, Wenjing Zhao, Li Song, Xingsong Zhang, Lei Yang, Min Tao
BackgroundARID3B (AT-rich interaction domain 3B) has been demonstrated to be associated with the progression and patient prognosis of several human tumors. We conducted the present study to investi...
-
Lung Cancer and Risk Factors in Lebanon: Epidemiology, Temporal Trends, and Comparison to Countries From Different Regions in the World Cancer Control (IF 2.6) Pub Date : 2023-04-18 Najla A. Lakkis, Umayya M. Musharafieh, Hanane G. Issa, Mona H. Osman
BackgroundLung cancer (Lca) is the leading cause of cancer morbidity and mortality worldwide. This study examines the Lca incidence and trends in Lebanon and compares them to regional and global on...
-
Is It Time to Expand Our Definition of “Clinical Utility”? Cancer Control (IF 2.6) Pub Date : 2023-04-14 Steven Sorscher
Currently, genetic tests that predict cancer risk or risk of recurrence in patients who have had their cancer treated with curative intent must have proven “clinical utility” to be recommended by t...
-
Higher Levels of Tumour-Infiltrating Lymphocytes (TILs) are Associated with a Better Prognosis, While CDK5 Plays a Different Role Between Nonmetastatic and Metastatic Colonic Carcinoma Cancer Control (IF 2.6) Pub Date : 2023-04-11 Qinghua Wang, Ruihua Yin, Xiaoxiao Chen, Bin Hu, Bingjing Jiang, Wanfen Tang, Xia Zhang, Xiayun Jin, Mingliang Ying, Jianfei Fu
ObjectiveWe investigated the prognostic value of cyclin-dependent kinase 5 (CDK5) in a true population-based cohort of patients with colon cancer.Methods1. Immunohistochemical (IHC) staining was us...
-
Quality of Life in Breast Cancer Patients: A Systematic Review of the Qualitative Studies Cancer Control (IF 2.6) Pub Date : 2023-04-04 Zohreh Heidary, Marjan Ghaemi, Batool Hossein Rashidi, Omid Kohandel Gargari, Ali Montazeri
ObjectiveQuality of life (QoL) in breast cancer patients is still an important topic. Despite numerous quantitative scales, qualitative studies can help to in-depth understand the QoL of breast can...
-
Differentiation of Bone Metastasis in Elderly Patients With Lung Adenocarcinoma Using Multiple Machine Learning Algorithms Cancer Control (IF 2.6) Pub Date : 2023-04-03 Cheng-Mao Zhou, Ying Wang, Qiong Xue, Yu Zhu
ObjectiveWe tested the performance of general machine learning and joint machine learning algorithms in the classification of bone metastasis, in patients with lung adenocarcinoma.MethodsWe used R ...
-
Qualitative Findings From a Survey on Patient Experiences and Satisfaction with Lung Cancer Screening Cancer Control (IF 2.6) Pub Date : 2023-03-27 Jaileene Pérez-Morales, Rashmi Pathak, Monica Reyes, Haley Tolbert, Rajwantee Tirbene, Jhanelle E. Gray, Vani N. Simmons, Matthew B. Schabath, Gwendolyn P. Quinn
BackgroundTo reveal successes and potential limitations of the lung cancer screening program, we conducted a survey that included both quantitative and open-ended questions to measure patient exper...
-
Prognostic Value of En-Block Radical Bowel Resection in Advanced Ovarian Cancer Surgery With HIPEC Cancer Control (IF 2.6) Pub Date : 2023-03-23 T. Panoskaltsis, C. Papadimitriou, N. Pallas, C. Karamveri, D. Kyziridis, C. Hristakis, V. Kiriakopoulos, A. Kalakonas, D. Vaikos, C. Tzavara, A. A. Tentes
PurposeTo identify prognostic factors of survival and recurrence in advanced ovarian cancer patients undergoing radical surgery and HIPEC.MethodsIn a single Department of Surgical Oncology, Periton...
-
Delivering Genetic Testing for Patients with Prostate Cancer: Moving Beyond Provider Knowledge as a Barrier to Care Cancer Control (IF 2.6) Pub Date : 2023-03-22 Christine M. Gunn, Emma X. Li, Gretchen A. Gignac, Magdalena Pankowska, Stephanie Loo, Kimberly Zayhowski, Catharine Wang
IntroductionThe 2018 National Comprehensive Cancer Network guidelines for prostate cancer genetic testing expanded access to genetic services. Few studies have examined how this change has affected...
-
Feasibility of Single - Encounter Telemedicine Lung Cancer Screening: A Retrospective Cohort Study in an Underserved Population Cancer Control (IF 2.6) Pub Date : 2023-03-19 Jessica Magarinos, Lynde Lutzow, Chandra Dass, Grace X. Ma, Cherie P. Erkmen
BackgroundCOVID-19 forced a delay of non-essential health services, including lung cancer screening. Our institution developed a single-encounter, telemedicine (SET) lung cancer screening whereby p...
-
Advance Care Planning With Black Women with Breast Cancer: A Community Health Worker Model Cancer Control (IF 2.6) Pub Date : 2023-03-14 Marcia M. Tan, Dario M. Villamar, Clarissa Huard, Lian Nicholson, Heidy N. Medina, Patricia I. Moreno
BackgroundDespite the importance of advance care planning (ACP), a process that optimizes future medical treatment and end-of-life care, for at-risk populations, rates of patient-provider ACP conve...
-
Information Architects: Using Community-Engaged and Qualitative Methods to Design a Technology-Based Nutrition and Cancer Risk Intervention for Rural Adults Cancer Control (IF 2.6) Pub Date : 2023-03-15 Melissa J. Vilaro, Kathryn McAlindon, Gillian Mertens, Taylor Ashley, Mohan Zalake, Eric J. Cooks, Janice L. Krieger
BackgroundNearly half of all cancer deaths are preventable through modification or avoidance of key risk factors. As such, there is a growing urgency to identify effective, low-resource, and scalab...
-
Perspectives on Self-Sampling for Cancer Screening From Staff at Federally Qualified Health Centers in Rural and Segregated Counties: A Preliminary Qualitative Study Cancer Control (IF 2.6) Pub Date : 2023-03-09 Jayme Wood, Kelsey C. Stoltzfus, Madyson Popalis, Jennifer L. Moss
BackgroundSelf-sampling for colorectal and cervical cancer screening can address the observed geographic disparities in cancer burden by alleviating barriers to screening participation, such as acc...
-
Lung Cancer Screening Knowledge in Four Internal Medicine Programs Cancer Control (IF 2.6) Pub Date : 2023-03-09 Samuel Urrutia Argueta, Nishraj Basnet, Owais Abdul-Kafi, Nasser Hanna
IntroductionLung cancer remains the leading cause of cancer-related death in the United States. Low density CT (LDCT) has been shown to reduce mortality in high-risk populations. Recognizing and mi...
-
The Combination of JAK2V617F Allele Burden and WT1 Expression can Be Helpful in Distinguishing the Subtype of MPN Patients Cancer Control (IF 2.6) Pub Date : 2023-03-09 Sanyun Wu, Ping Luo, Tuerxunayi Rouzi, Yalan Yu, Bei Xiong, Yingying Wang, Xuelan Zuo
IntroductionClassical Philadelphia-negative myeloproliferative neoplasm (MPN) includes Essential Thrombocythemia (ET), Polycythemia Vera (PV) and Primary Myelofibrosis (PMF). The JAK2V617F mutation...
-
Cross-Sectional Study for Investigation of the Association Between Modifiable Risk Factors and Gastrointestinal Cancers at a Tertiary Hospital in Ghana Cancer Control (IF 2.6) Pub Date : 2023-03-08 Naa Adzoa Adzeley Boi-Dsane, Vincent Amarh, Sandra Enyonam Tsatsu, Sarah Vuunipuo Bachelle, Antoinette Afua Asiedua Bediako-Bowan, Nii Koney-kwaku Koney, Bartholomew Dzudzor
BackgroundMalignancies affecting the gastrointestinal tract are among the principal threats to global public health. In Ghana, these cancers are responsible for a significant number of hospitalizat...
-
Mammographic Density Reduction is Associated to the Prognosis in Asian Breast Cancer Patients Receiving Hormone Therapy Cancer Control (IF 2.6) Pub Date : 2023-03-03 Wei-Chung Shia, Li-Sheng Lin, Hwa-Koon Wu, Chih-Jung Chen, Dar-Ren Chen
IntroductionUsing mammographic density as a significant biomarker for predicting prognosis in adjuvant hormone therapy patients is controversial due to the conflicting results of recent studies. Th...
-
The Use of Artificial Intelligence for Complete Cytoreduction Prediction in Epithelial Ovarian Cancer: A Narrative Review Cancer Control (IF 2.6) Pub Date : 2023-02-27 Giulia Parpinel, Maria Elena Laudani, Elisa Piovano, Paolo Zola, Fabrice Lecuru
IntroductionIn patients affected by epithelial ovarian cancer (EOC) complete cytoreduction (CC) has been associated with higher survival outcomes. Artificial intelligence (AI) systems have proved c...
-
Unusual Microsatellite-Instable Mixed Neuroendocrine and Non-neuroendocrine Neoplasm: A Clinicopathological Inspection and Literature Review Cancer Control (IF 2.6) Pub Date : 2023-02-25 Daniela Pereira, Daley White, Michael Mortellaro, Kun Jiang
BackgroundMixed neuroendocrine and non-endocrine neoplasms (MiNENs) are challenging to diagnose and manage clinically. The current understanding of MiNENs’ pathobiology, molecular mechanisms, and m...
-
Blocking CD47-SIRPα Signal Axis as Promising Immunotherapy in Ovarian Cancer Cancer Control (IF 2.6) Pub Date : 2023-02-24 Xukai Luo, Yini Shen, Wu Huang, Yiting Bao, Jiahang Mo, Liangqing Yao, Lei Yuan
Among the three primary gynecological malignancies, ovarian cancer has the lowest incidence but the worst prognosis. Because of the poor prognosis of ovarian cancer patients treated with existing t...
-
Survival Outcomes of Patients with International Federation of Gynecology and Obstetrics Stage IV Ovarian Cancer: Cytoreduction Still Matters Cancer Control (IF 2.6) Pub Date : 2023-02-23 Yao Xiao, Hua Linghu
PurposeThere is still no consensus on the therapeutic strategies for patients with International Federation of Gynecology and Obstetrics (FIGO) stage IV ovarian cancer (OC). We aim to outline the c...
-
Determining the Factors Predicting the Response to Anti-HER2 Therapy in HER2-Positive Breast Cancer Patients Cancer Control (IF 2.6) Pub Date : 2023-02-22 Ji Young You, Kyoung Hwa Park, Eun Sook Lee, Youngmee Kwon, Kyoung Tae Kim, Seungyoon Nam, Dong Hee Kim, Jeoung Won Bae
PurposeWe aimed to identify the differently expressed genes or related pathways associated with good responses to anti-HER2 therapy and to suggest a model for predicting drug response in neoadjuvan...
-
Unobvious Neutrophil Extracellular Traps Signification in the Course of Oral Squamous Cell Carcinoma: Current Understanding and Future Perspectives Cancer Control (IF 2.6) Pub Date : 2023-02-22 Marzena Garley
Background: The current standards of treatment for oral squamous cell carcinoma (OSCC) include surgery, radiotherapy, and chemotherapy. In recent years, research on the effectiveness of immunothera...
-
Sleep Quality and Associated Factors Among Adult Cancer Patients on Treatments at Tikur Anbessa Specialized Hospital Oncology Unit, Addis Ababa, Ethiopia, 2021 Cancer Control (IF 2.6) Pub Date : 2023-02-22 Eshetu Abebe, Berhanu Wordofa Giru, Abdissa Boka
BackgroundPatients with cancer frequently reported sleep problems during their treatments which can affect their sleep quality have an impact on patients’ quality of life (QOL).Objectiveto assess t...
-
Status and Determinants of Early Detection of Oral Premalignant and Malignant Lesions in India Cancer Control (IF 2.6) Pub Date : 2023-02-21 Tulika Shruti, Divya Khanna, Aqusa Khan, Abhishek Dandpat, Manish Tiwari, Arjun G. Singh, Aseem Mishra, Anupama Shetty, Praveen Birur, Pankaj Chaturvedi
It has been over four decades since the launch of the National Cancer Control Programme in India, yet the cancer screening rates for oral cancer remain unremarkable. Moreover, India is bracing a la...
-
Atypical Fibroxanthoma: Outcomes from a Large Single Institution Series Cancer Control (IF 2.6) Pub Date : 2023-02-10 Erin McClure, Michael J Carr, Ayushi Patel, Syed Mahrukh Hussnain Naqvi, Youngchul Kim, Michael Harrington, Wayne Cruse, Ricardo J Gonzalez, Vernon K Sondak, Amod A Sarnaik, Jane L Messina, Jonathan S Zager
BackgroundAtypical fibroxanthomas (AFX) are rare malignant cutaneous neoplasms. Unfortunately, limited clinicopathologic and outcomes data on this cancer exists.ObjectiveWe report the clinical, pat...
-
Research Progress of Tumor Microenvironment Targeted Therapy for Clear Cell Renal Cell Carcinoma Cancer Control (IF 2.6) Pub Date : 2023-02-10 Yongqiang Huang, Hong Sun, Pu Guo
Renal clear cell carcinoma (ccRCC) and the tumor microenvironment (TME) influence each other, leading to the tumor microenvironment that can guide the corresponding treatment. With the deepening of...